StratDeckNOVO-B.CO

Novo Nordisk A/S

NOVO-B.CO✓
Share

Healthcare · Drug Manufacturers - General · Denmark

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.

Price276.45DKK
1D-3.44%
Market cap191B
AnalystsHold23
Next earnings4 Nov
Loading chart…

Trade ideas

NOVO-B.CO isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusHold23
Mean score2.96
Mean target310.17+12.20%
Target range203.00–457.00

Value vs sector peers

#5 of 26 in HealthcareCheap for a reason78
  • Fwd P/E12.880
  • P/B5.645
  • Yield4.2%91
  • P/E10.7100
  • Rev growth+2.1%12

Nearest in Healthcare

  1. #3PFEPfizer Inc.Cheap for a reason81
  2. #4BMYBristol-Myers Squibb CompanyCheap for a reason78
  3. #5NOVO-B.CONovo Nordisk A/SCheap for a reason78
  4. #6CVSCVS Health CorporationCheap for a reason77

Fundamentals

P/E10.7
Forward P/E12.8
Price / book5.61
Dividend yield4.23%
Beta0.34
52-week range224.25–409.9528/100
ADV (USD)182M
Relative volume1.4
10d avg volume3.97M
Revenue growth+2.10%
EPS growth-20.60%

Performance

1D-3.44%
7D-7.51%
1M-6.52%
3M-2.53%
6M+17.23%
YTD-10.95%

In the briefing and the feed

Briefing for 15 Sept

Neither the briefing nor the research feed has named NOVO-B.CO.

Catalysts

Next earnings: 4 Nov

Trade idea history

No trade idea has fired on NOVO-B.CO since the ledger opened.

Get it by email

The board NOVO-B.CO sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.